Pricing
  1. JP-listed companies
  2. TRANS GENIC GROUP INC.
  3. Balance sheet

TRANS GENIC GROUP INC.【JP:2342】Balance sheet

Market cap
¥4.6B
P/E ratio
113.3x
Transgenics Group supports drug development through specialized lab services like genetically modified mice production and pharmaceutical testing, while also providing business consulting and importing various products from electrical equipment to tableware.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Income statementBalance sheetCash flowOther
2014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Cash and cash equivalents -9461,0541,0591,7731,2781,6033,0304,6193,4592,4782,555
Marketable securities, current -400----200-6---
Total cash & short-term investments-1,3461,0541,0591,7731,2781,8033,0304,6243,4592,4782,555
Accounts receivable, net-4514884176256941,0211,1398941,0831,3431,195
Inventories-1252542477126881,0241,3531,5931,349
Total current assets-1,9341,7191,6973,0722,9034,3345,8127,7107,5626,5506,699
Property, plant and equipment, net-1,4071,4291,4761,5092,1622,0702,1251,9931,9922,1422,055
Marketable securities, non-current -10552515668565313163110106129108
Total non-current assets-1,6402,1862,2052,8623,5723,2383,1072,7313,1113,2612,888
Total assets -3,5743,9053,9025,9356,4757,5728,91910,44110,6739,8119,586
Accounts payable----------276413
Short-term debt-----130500100390170448680
Long-term debt, current ----210102171223324478453525
Total current liabilities-4244954888561,1322,0052,1652,6592,7442,4343,272
Total non-current liabilities-3733412417374571,1501,7171,1451,8061,3781,458
Total liabilities -7968367291,5931,5893,1553,8823,8044,5503,8134,730
Retained earnings--83-681233236-2058432,6582,1472,067928
Stockholders' equity2,7652,7773,0703,1734,3424,8874,4175,0376,6376,1235,9984,856
Working capital----------